Works matching AU Formenti, Silvia C

Results: 82
    1
    2
    3
    4
    5
    6

    Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control.

    Published in:
    2021
    By:
    • Lhuillier, Claire;
    • Rudqvist, Nils-Petter;
    • Takahiro Yamazaki;
    • Tuo Zhang;
    • Charpentier, Maud;
    • Galluzzi, Lorenzo;
    • Dephoure, Noah;
    • Clement, Cristina C.;
    • Santambrogio, Laura;
    • Xi Kathy Zhou;
    • Formenti, Silvia C.;
    • Demaria, Sandra;
    • Yamazaki, Takahiro;
    • Zhang, Tuo;
    • Zhou, Xi Kathy
    Publication type:
    journal article
    7
    8
    9
    10

    Impact of radiation therapy dose, fractionation, and immunotherapeutic partner in a mouse model of hormone receptor–positive mammary carcinogenesis.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 5, p. 934, doi. 10.1093/jnci/djae329
    By:
    • Buqué, Aitziber;
    • Bloy, Norma;
    • Petroni, Giulia;
    • Jiménez-Cortegana, Carlos;
    • Sato, Ai;
    • Iribarren, Cristina;
    • Yamazaki, Takahiro;
    • Galassi, Claudia;
    • Hensler, Michal;
    • Bhinder, Bhavneet;
    • Guarracino, Andrea;
    • Rippon, Brady;
    • Beltran-Visiedo, Manuel;
    • Soler-Agesta, Ruth;
    • Pannellini, Tania;
    • Fucikova, Jitka;
    • Demaria, Sandra;
    • Zhou, Xi Kathy;
    • Elemento, Olivier;
    • Formenti, Silvia C
    Publication type:
    Article
    11
    12
    13

    Trial watch: Immune checkpoint blockers for cancer therapy.

    Published in:
    OncoImmunology, 2017, v. 6, n. 11, p. N.PAG, doi. 10.1080/2162402X.2017.1373237
    By:
    • Vanpouille-Box, Claire;
    • Lhuillier, Claire;
    • Bezu, Lucillia;
    • Aranda, Fernando;
    • Yamazaki, Takahiro;
    • Kepp, Oliver;
    • Fucikova, Jitka;
    • Spisek, Radek;
    • Demaria, Sandra;
    • Formenti, Silvia C.;
    • Zitvogel, Laurence;
    • Kroemer, Guido;
    • Galluzzi, Lorenzo
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Author Correction: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I–III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial.

    Published in:
    2024
    By:
    • Altorki, Nasser K.;
    • Walsh, Zachary H.;
    • Melms, Johannes C.;
    • Port, Jeffery L.;
    • Lee, Benjamin E.;
    • Nasar, Abu;
    • Spinelli, Cathy;
    • Caprio, Lindsay;
    • Rogava, Meri;
    • Ho, Patricia;
    • Christos, Paul J.;
    • Saxena, Ashish;
    • Elemento, Olivier;
    • Bhinder, Bhavneet;
    • Ager, Casey;
    • Amin, Amit Dipak;
    • Sanfilippo, Nicholas J.;
    • Mittal, Vivek;
    • Borczuk, Alain C.;
    • Formenti, Silvia C.
    Publication type:
    Correction Notice
    23
    24

    Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I–III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-44195-x
    By:
    • Altorki, Nasser K.;
    • Walsh, Zachary H.;
    • Melms, Johannes C.;
    • Port, Jeffery L.;
    • Lee, Benjamin E.;
    • Nasar, Abu;
    • Spinelli, Cathy;
    • Caprio, Lindsay;
    • Rogava, Meri;
    • Ho, Patricia;
    • Christos, Paul J.;
    • Saxena, Ashish;
    • Elemento, Olivier;
    • Bhinder, Bhavneet;
    • Ager, Casey;
    • Amin, Amit Dipak;
    • Sanfilippo, Nicholas J.;
    • Mittal, Vivek;
    • Borczuk, Alain C.;
    • Formenti, Silvia C.
    Publication type:
    Article
    25
    26
    27
    28
    29
    30

    Peripheral T-cell lymphoma.

    Published in:
    1989
    By:
    • Armitage, James O.;
    • Greer, John P.;
    • Levine, Alexandra M.;
    • Weisenburger, Dennis D.;
    • Formenti, Silvia C.;
    • Bast, Martin;
    • Conley, Sue;
    • Pierson, Jene;
    • Under, James;
    • Cousar, John B.;
    • Nathwani, Bharat N.;
    • Armitage, J O;
    • Greer, J P;
    • Levine, A M;
    • Weisenburger, D D;
    • Formenti, S C;
    • Bast, M;
    • Conley, S;
    • Pierson, J;
    • Linder, J
    Publication type:
    journal article
    31

    Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th–December 1st, 2022).

    Published in:
    Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04117-3
    By:
    • Ascierto, Paolo A.;
    • Avallone, Antonio;
    • Bifulco, Carlo;
    • Bracarda, Sergio;
    • Brody, Joshua D.;
    • Emens, Leisha A.;
    • Ferris, Robert L.;
    • Formenti, Silvia C.;
    • Hamid, Omid;
    • Johnson, Douglas B.;
    • Kirchhoff, Tomas;
    • Klebanoff, Christopher A.;
    • Lesinski, Gregory B.;
    • Monette, Anne;
    • Neyns, Bart;
    • Odunsi, Kunle;
    • Paulos, Chrystal M.;
    • Powell Jr., Daniel J.;
    • Rezvani, Katayoun;
    • Segal, Brahm H.
    Publication type:
    Article
    32
    33
    34
    35

    MRI-LINAC: A transformative technology in radiation oncology.

    Published in:
    Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1117874
    By:
    • Ng, John;
    • Gregucci, Fabiana;
    • Pennell, Ryan T.;
    • Nagar, Himanshu;
    • Golden, Encouse B.;
    • Knisely, Jonathan P. S.;
    • Sanfilippo, Nicholas J.;
    • Formenti, Silvia C.
    Publication type:
    Article
    36
    37
    38
    39

    DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity.

    Published in:
    Nature Communications, 2017, v. 8, n. 6, p. 15618, doi. 10.1038/ncomms15618
    By:
    • Vanpouille-Box, Claire;
    • Alard, Amandine;
    • Aryankalayil, Molykutty J.;
    • Sarfraz, Yasmeen;
    • Diamond, Julie M.;
    • Schneider, Robert J.;
    • Inghirami, Giorgio;
    • Coleman, C. Norman;
    • Formenti, Silvia C.;
    • Demaria, Sandra
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50